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THE INTERRELATIONSHIP BETWEEN TREATMENT, ETHNICITY, AND STRUCTURED
EXERCISE IN CLINICAL POPULATIONS
Abstract
By Amanda Marie Figueroa Lopez
University of the Pacific
2022
Cancer is the second leading cause of death, with about approximately 1.9 million
Americans being diagnosed each year. Yet, it has high survival rates with the help of advancing
treatments like radiation therapy. Cancer patients and survivors are contingent on experiencing a
decline in physical functioning, quality of life, and physiological parameters. Treatment is
effective and can prolong life expectancy but can be deleterious to a patient’s health. Parallel
with cancer's impact on Americans is cardiovascular disease. Cardiovascular disease is
responsible for 1 in 4 deaths. The development of cardiovascular disease is not spread
accordantly among all ethnicities. Hispanics are more likely to have a type of cardiovascular
disease. Structured exercise has consistently been established to be an effective countermeasure
for diminishing cardiovascular risk factors, adverse side effects, and symptoms of cancer and
cancer treatment. The purpose of this thesis is to evaluate the effect of structured exercise to
address 3 questions with limited data. The evaluation included the incidence of cardiovascular
disease in at-risk Hispanics, physiological adaptions to a structured exercise program, and the
effect of radiation therapy on exercise outcomes. Subjects for each study were enrolled in a
10-week structured exercise program consisting of aerobic, resistance, and flexibility exercises.
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Conclusions were no difference in exercise benefits in ethnicity but exercise did improve cancer
survivors’ physical functioning in all domains.
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CHAPTER 1: INTRODUCTION

It is predicted that in 2022 approximately 1.9 billion people will be diagnosed with
cancer worldwide (Siegel et al., 2021). Cancer is a “multigenic and multicellular disease that can
arise from all cell types and organs with a multi-factorial etiology,” (Baskar et al., 2012). In the
United States, approximately 1.9 million Americans are diagnosed with cancer each year, that’s
about 5,000 new cases each day. An estimated 600,000 people in the United States will die from
cancer, securing it the second leading cause of death (CDC, 2022). In spite of that, there are over
12 million cancer survivors and with advancements in treatment and diagnosis, the number is
expected to grow to over 20 million by 2026 (Miller et al., 2016).
A few cancer treatment approaches consist of radiation therapy, chemotherapy, surgery,
immunotherapy, and hormonal therapy (Wang et al., 2018). Radiation therapy (RT), also known
as radiotherapy, treats approximately 50% of cancer patients and has become an essential and
effective modality implemented in worldwide cancer care (Baskar et al., 2012). Its continuous
advancements since it was first attempted in 1896 by Emil Grubee administer the potential for it
to improve the rates of cure of 3.5 million people each year (Jaffray and Gospodarowicz, 2015).
The benefits of RT encompass cost-efficiency, prolonged life expectancy, organ preservation, and
control of tumor growth (Thariat et al., 2013).
Cancer is not a universal disease that is characterized to be equivalent among all
survivors. Cancer is characterized by the dissimilarity of the individual cancer survivor (age,
gender, race, comorbidities, etc.) and disease presentation (tissue, location, stage, etc.), of the
nature that corresponds with the diversity of psychological and physical consequences patients
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face (Brown et al., 2012). There are psychological and physical symptoms and side effects that
nearly all cancer survivors are subject to experience (Schmitz et al., 2010). Physical effects
include elevated cardiovascular risks, fatigue, pulmonary dysfunction, sexual dysfunction,
lymphedema, neuropathy, cognitive dysfunction, deterioration in body composition,
musculoskeletal issues, and diminished physical function (Gegechkori et al., 2017). Due to
compromised physical function compounding many of the other symptoms, it positions cancer
survivors in a vulnerable place to obtain additional health concerns, including early death
(Brown et al., 2012).
Ahead of cancer leading the cause of death is heart disease, which is one of the
conditions of cardiovascular disease (CVD) which affects the heart and blood vessels (World
Health Organization, 2022). In 2020, deaths attributed to CVD increased by 18.7% from 2010 to
a total of approximately 19 million (Virani et al., 2022). There are known predictors (e.g.,
obesity, hypertension, and dyslipidemia) that increase the odds of developing CVD but it is
dependent on the level of progression. However, the risk is not proportionate among all
ethnicities (Ferdinand et al., 2017). Despite increases in diabetes and obesity in lower
socioeconomic groups, Hispanic Americans often display markers of elevated risk. Current
research subsumes persistent evidence that illustrates Hispanics being affected by excessive rates
of cardiovascular risk factors even after adjusting for age, body mass index, and socioeconomic
status (Shaw et al., 2018). While Hispanic Americans often display markers of elevated risk,
they have longer life expectancies than their non-Hispanic counterparts (Swenson et al., 2002).
An understanding of the distribution and contribution of risk factors among different ethnic
groups may help in specifying treatment interventions more appropriately.
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An antidote to the ramifications of cancer and CVD is exercise. Exercise is low cost and
accessible for all. Consistent data demonstrates exercise programs improve cancer-related
symptoms and cancer treatment-related side effects, and health-related quality of life (Silver et
al., 2015). Exercise during and after adjuvant cancer therapy, such as RT, serves as an effective
method to subdue negative psychological and physical side effects and symptoms from cancer
and treatment, limit disease progression, and directly benefit cancer treatment (Schmitz et al.,
2010; Brown et al., 2012). In regards to CVD, increasing levels of exercise improve
cardiorespiratory fitness levels for all ages, races, ethnicity, and both sexes which is effective in
the prevention of CVD (Lavie et al., 2019). Cardiorespiratory fitness is significant to enhance
the strength of the physiological benefits including reduced blood pressure, improved heart rate
variability, improved insulin sensitivity, reduction in hypertension, and reduction in depression
that goes well beyond the obviation of the progression of CVD (Nauman et al., 2017).
Cancer and CVD, are the two utmost impactful diseases people encounter worldwide.
The problem we confront is established that cancer and cancer treatment effects and symptoms
have consequences detrimental to one's health. The other problem is the disproportionate
differences in CVD risk factors among at-risk Hispanic and non-Hispanic adults.
This thesis will address three questions with limited data. The three questions I seek to
bring additional findings to are; is structured exercise effective in improving cardiovascular and
functional capabilities in cancer survivors, are Hispanics more vulnerable to CVD risk factors,
and the incidence of adverse cardiovascular events, and lastly how does RT affect structured
exercise outcomes in cancer survivors.
Above I mention three areas with limited research on clinical populations and I found

15
structured exercise to improve physical functioning in nearly every domain and to benefit
Hispanic and non-Hispanic subjects similarly. In the population of cancer survivors, we found
exercise to improve strength, aerobic capacity, and flexibility. Also, we observed that structured
exercise may be an effective way to mitigate some of the health consequences associated with
radiation therapy.
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CHAPTER 2: EXERCISE AND THE CANCER PATIENT: FUNCTION IMPROVES
INDEPENDENT OF CARDIOVASCULAR AND ANTHROPOMETRIC CHANGES

Abstract
Background
Each year, approximately 1.9 million Americans are diagnosed with cancer, that's about
5,000 new cases each day. The consequences of cancer and its associated treatment include
elevations in cardiovascular risk, deteriorating body composition, and diminishing physical
function. Exercise is an effective countermeasure; however, limitations in adherence may
compromise the magnitude of improvement experienced.
Purpose. To evaluate cardiovascular, anthropometric, and functional adaptations to an
exercise program in cancer survivors.
Methods. We conducted a 10-week exercise intervention on 157 cancer survivors; 58
were retained through follow-up. At baseline, we recorded demographic, anthropometric,
cardiovascular, and functional data. Anthropometric measurements were weight, body mass
index (BMI), and body fat percent (BF%). Cardiovascular measurements were blood pressure
and heart rate. Functional tests were VO2 max, six-minute walk, timed up-and-go, chair stand,
sit-to-stand, arm curl, grip strength, Universal Machine (UM) push and pull, epic lift,
sit-and-reach, functional reach, and back scratch. Paired-samples t-tests measured changes from
baseline to follow-up.
Results. Anthropometric variables did not change: body weight (p=0.585), BMI
(p=0.477), and BF% (p=0.367). Cardiovascular variables did not change: systolic blood
pressure (p=0.560), diastolic pressure (p=0.292), and heart rate (p=1.000). Improvement was

17
detected in 11 of 13 functional tests: VO2 max (p=0.005), six-minute walk (p<0.001), timed
up-and-go (p<0.001), chair stand (p<0.001), sit-to-stand (p=0.005), arm curl (p<0.001), grip
strength (p<0.001), UM push (p<0.001), UM pull (p<0.001), epic lift (p=0.005), and functional
reach (p=0.001). Mean values improved in sit-and-reach (p=0.321) and back-scratch (p=0.099),
but pre-post comparisons were not significant.
Conclusion. Exercise did not affect anthropometric or cardiovascular profiles, but
physical functioning improved in nearly every domain. In this population, maintenance of
functional capacity can help preserve the ability to perform tasks of daily living, and it is
associated with survival. Although we found exercise to improve strength, aerobic capacity, and
flexibility, the high rate of attrition is a potential limitation; further research is necessary to
confirm our findings.
Introduction
It is predicted that in 2022 approximately 1.9 billion people will be diagnosed with
cancer and an estimated 600,000 people in the United States will die from cancer (Siegal et al.,
2022). Cancer is the second leading cause of death behind heart disease in the United States
(CDC, 2022). Despite being ranked second there are over 12 million cancer survivors and with
advancements in treatment and diagnosis, the number is expected to grow to over 20 million by
2026 (Miller et al., 2016). Nearly all cancer survivors are subject to experience psychological
and physical symptoms and side effects (Schmitz et al., 2010). The diversity of the individual
cancer survivor (age, gender, race, comorbidities, etc.) and disease presentation (tissue, location,
stage, etc.) corresponds with the diversity of psychological and physical consequences patients
face (Brown et al., 2012). Physical effects include elevated cardiovascular risks, fatigue,
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pulmonary dysfunction, sexual dysfunction, lymphedema, neuropathy, cognitive dysfunction,
deterioration in body composition, musculoskeletal issues, and diminished physical function
(Gegechkori et al., 2017). Compromised physical function can compound many of the other
symptoms, leaving cancer survivors vulnerable to additional health concerns, including early
death (Brown et al., 2012).
Exercise interventions for cancer patients and survivors have been established as safe and
beneficial (Schmitz et al., 2010). Recommending the appropriate exercise plan faces a set of
challenges and as a result, the prescription is often overlooked by oncology care providers (Stout
et al., 2005-2017). Smaradottir et al. (2017) presented that patients consistently reported no
recollection of physician-initiated conversations about exercise during treatment. The American
College of Sports Medicine (ACSM) provided guidelines on exercise for cancer survivors
and it included the risk-benefit equation and addressed questions of safety and benefits (Wolin et
al., 2012). The exercise guidelines by the US Department of Health and Human Services 2008
Physical Activity Guidelines for Americans (PAGA) that provide the type and duration of
exercise are the same recommendations for cancer survivors (Table 1) (Wolin et al., 2012).

Table 1.
Summary of PAGA exercise guidelines for Americans. (Wolin et al., 2012)
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Exercise programs have been used to improve cancer-related symptoms and cancer
treatment-related side effects, and health-related quality of life (Silver et al., 2015). Cancer
patients' exercise interventions have demonstrated efficacy in improving quality of life domains
(QOL), physical functioning, cancer-related fatigue, cardiovascular fitness, sleep quality,
psychological and social well-being, and self-esteem (Knobf et al., 2007). In this context, QOL
domains include physical, social, psychological, and spiritual areas of one's life. Evidence of the
physical benefits of exercise also include improved recovery, decreased adverse side effects
before and after treatment, prolonged survival, and reduced risk of cancer recurrence
(Rajarajeswaran et al., 2009). Although exercise appears to be an effective countermeasure,
limitations in adherence may diminish the magnitude of improvement experienced (Schmitz et
al., 2010). In a sample of 57 prostate cancer survivors, participation in a thrice-weekly aerobic,
resistance, and flexibility exercise program elicited an increase in physical functioning and lower
body muscle strength (Galvão et al., 2018). McGovern et al.'s (2022) meta-analysis summarized
during adjuvant chemotherapy and/or radiation therapy 1,910 cancer patients from 20 articles,
participated in more than 6 weeks of resistance training which prompted improvements in
muscle strength and lean mass. By proper evaluation of cancer patients, post-treatment, and
assistance from ACSM cancer survivor exercise guidelines clinicians can prescribe exercise
interventions to address complex negative stressors across the cancer control continuum
(Schmitz et al., 2010).
The purpose of this paper is to evaluate changes in cardiovascular, anthropometric, and
functional adaptations in cancer patients from an exercise program by comparing baseline and
follow-up assessments.
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Research Hypothesis
There will be a significant augmentation of cardiovascular, anthropometric, and
functional adaptations of cancer survivors in an exercise program.
Purpose
The purpose of this paper is to evaluate cardiovascular, anthropometric, and functional
adaptations to an exercise program in cancer survivors.
Null Hypothesis
There will be no significant augmentation of cardiovascular, anthropometric, and
functional adaptations of cancer survivors in an exercise program.
Delimitations
Noncancer survivors and cancer survivors are not recommended safe to participate by
their physicians.
Limitations
This study is not a randomized control trial. Exercise programs were individualized and
created by the head clinician. Data collection and assessments were conducted by a single
clinician. The low rate of adherence is a potential limitation.
Methodology
Participants/Consent
157 cancer survivors were screened and evaluated by the physician involved in the
treatment of the patient to determine that no medical condition would preclude their eligibility
for participation at the time of consent. The protocol and signed informed consent were
approved by the Institutional Review Boards of the hospital delivering care and the University of
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the Pacific. Signed consent was obtained from each participant. Participants' anthropometric,
cardiometabolic, and functional changes were measured pre-and post-training.
Data Collection
At baseline and follow-up, a single clinician conducted all assessments. The sample
consisted of 157 cancer patients and 58 completed the study. Anthropometric measurements
were weight, body mass index (BMI), and body fat percent (BF%). Cardiovascular
measurements were blood pressure (systolic and diastolic blood pressure) and resting heart rate.
Physical functional tests were VO2 max, six-minute walk, timed up-and-go, timed sit-to-stand,
chair stand, arm curl, grip strength, Universal Machine (UM) push and pull, epic lift,
sit-and-reach, functional reach, and back scratch.
Exercise Intervention
Subjects participated in supervised biweekly group exercise classes that included aerobic,
flexibility, and resistance training components for 10 weeks. Exercise programs were created by
the head clinician and specific to each individual. Four aerobic exercises were performed in
six-minute intervals, for a total of 24 aerobic minutes. Aerobic exercises included; treadmill,
Nu-Step, UBE, and recumbent bike. Patients were asked to exert themselves between 60-75% of
maximum heart rate. If the patient was on heart medication, they were asked to exert themselves
at a score between 12–14 via the Borg Rating of Perceived Exertion. Various resistance
exercises were performed; chest press, latissimus dorsi pulldowns, triceps extensions, standing
rows with therabands, bicep curls, wall squats, and step-ups. At the end of the exercise program,
all patients were reevaluated by the same clinician that conducted their baseline assessments. No
major adverse events were reported.
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Statistical Analysis
All statistical tests were conducted using SPSS version 24 (IBM SPSS Statistics, IBM
Corporation, Chicago, IL, USA). Descriptive statistics calculated sample characteristics at
baseline. Baseline data were compared to follow-up data using paired-samples t-tests on all
individuals who completed the study. Significance was set at p<0.05. Predictors that did not
meet significance were not included and were removed from the model.
Results
We conducted the intervention with 157 cancer patients at baseline and 99 subjects did
not complete the study. Changes are among subjects who completed the study (n=58).
Anthropometric Variables
There were no significant differences between pre-and post-training of anthropometric
measurements ( Figure 1). At follow-up subjects BMI (p=0.585) and body fat percentage (p=
0.477) did not change.
Cardiovascular Variables
There were no significant differences between pre-and post-training of cardiovascular
measurements ( Figure 1). At follow-up subjects resting heart rate (p= 1.000), systolic blood
pressure (p= 0.560), and diastolic blood pressure (p= 0.292) did not change.
Functional Tests
All physical function assessments are displayed in Figure 2. All measures of physical
function were significantly increased in the post-assessment in comparison to the pre-assessment.
Improvements in VO2 max (p=0.005), timed up-and-go (p<0.001), chair stand (p<0.001), arm
curl (p<0.001), grip strength (p<0.001), UM push (p<0.001), UM pull (p<0.001), epic lift
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(p=0.005), sit-to-stand (p=0.005), and functional reach (p=0.001) (see Table 2 and Table 3 for all
improvements). Figure 3 illustrates patients' improvement in a six-minute walk (p<0.001).
Table 2 displays mean values improved in sit-and-reach (p=0.321) and back-scratch (p=0.099),
but pre-post comparisons were not significant.

Figure 1. Cardiovascular and anthropometric assessment comparison of pre-and post- values.
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Figure 2. Physical function assessments comparison of pre-and post- values; displayed
significant improvements (p<0.05)
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Table 2
Physical functioning variables pre-and post- values using paired samples t-tests.
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Figure 3. Six-minute walk pre- and post- values.
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Table 3
Cardiometabolic variables pre- and post- values.
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Discussion
Since the mid-1970s decreases in cancer mortality rates have been improving in almost
all cancer types, specifically in lung, breast, prostate, and colorectal (Siegel et al., 2021). Seigel
et al. (2021) statistical analysis reported a decline of 31% translating to approximately 3.2
million fewer cancer deaths. Decline death rates are attributable to advancements in diagnosis,
management, and treatment (Sherman et al., 2005). As survival rates have increased and
continue to do so, so have interest in exercise programs for cancer patients. Exercise-oncology is
a new field of cancer care clinicians acquire intending to introduce exercise programs in the
management of cancer patients to receive benefits associated with exercises such as
improvements in QOL, fatigue, cardiovascular fitness, and body composition (Pollán et al.,
2020). Adopting exercise is becoming an important focus of attention because of the aid. In the
National Cancer Institute Cancer Trends Progress Report, the section on Cancer survivors and
physical activity stated in 2018 34% of cancer patients 18 years and older reported no physical
activity as compared to over 50% in 1997.
Our study evaluated the effects of cardiovascular, anthropometric, and functional
capacity of a 10-week exercise program that consisted of biweekly classes incorporating aerobic,
flexibility, and resistance training. The results exhibited favorable improvements in strength,
aerobic capacity, and flexibility at follow-up when compared to baseline. The duration of the
exercise program totaling 20 supervised exercise sessions had a positive impact. The
improvements in physical functioning align with prior meta-analysis and support the
effectiveness of exercise for cancer patients. Juvet et al., (2017) systematic review reported
short-term improvements in physical functioning and reduced fatigue in breast cancer patients
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from supervised exercise programs. The impact of exercise programs was also identified to have
beneficial outcomes of treatment side effects, tolerance to cancer treatments, and physical
function (Stout et al., 2005-2017).
Although our findings did not show a change in anthropometric variables, other
interventions were longer in duration as demonstrated in the meta-analysis published by Strasser
et al. The meta-analysis found that 2-3 days of whole-body resistance training 12 weeks to 6
months increases muscular strength, corrects muscular deficiencies, improves body composition
in the short and long term, and it improves pain and range of motion (Strasser et al., 2013). This
might explain why no change in body composition or fat percentage was found.
Conclusion
In conclusion, our findings illustrated significant physical functioning improvements at
follow-up, 11 of the 13 domains showed improvements. It provides evidence that supervised
exercise is safe and effective among cancer patients. These findings are useful to help guide
clinicians in exercise prescription and planning for cancer patients. However, the intervention
demonstrated no changes in body composition (weight, BMI, body fat percentage) or
cardiometabolic parameters (heart rate or blood pressure). The high rate of attrition is a potential
limitation. Further research is necessary to confirm our findings.
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CHAPTER 3: THE ROLE OF ETHNICITY IN DEVELOPING CARDIOVASCULAR
DISEASE IN AT-RISK POPULATIONS

Abstract
Background
In the U.S., cardiovascular disease (CVD) is responsible for 1 in 4 deaths. There are
known predictors (e.g., obesity, hypertension, and dyslipidemia) that increase the odds of
developing CVD; however, the risk is not proportionate among all ethnicities. While Hispanic
Americans often display markers of elevated risk, they have longer life expectancies than their
non-Hispanic counterparts. Further exploration of this phenomenon is necessary to elucidate
how risk engenders disease in different ethnic groups.
Purpose. To evaluate CVD risk factors and the incidence of adverse cardiovascular
events among at-risk Hispanic and non-Hispanic adults.
Methods. We enrolled 10 Hispanic and 41 non-Hispanic men and women with Type 2
diabetes in a 10-week exercise program. Prior to initiating exercise, we documented
demographic data, collected a health history, conducted 7 tests of physical functioning, and
measured cardiometabolic variables, including body mass index (BMI), body fat percent (BF%),
blood pressure, heart rate, and HBA1C. We repeated all assessments following the intervention.
Differences between ethnic groups in baseline values and exercise responses were evaluated with
independent-samples t-tests and chi-squared tests.
Results. Hispanic subjects had fewer diagnoses of hypertension (p=0.002) and no history
of heart attack, compared to 25% incidence among non-Hispanics (p=0.077). Hispanic subjects
were 8.1 years younger (p=0.032), 40% of them smoked (compared to 0%; p<0.001), and they
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had better body compositions as measured by BMI (p=0.038), BF% (p=0.021), and categorical
obesity (p=0.030). Physical functioning was slightly better among Hispanic subjects as
measured by the 6-minute walk (p=0.010) and functional reach (p=0.029). Participants who
completed the exercise program experienced an improvement in all assessments but grip
strength; there were no differences in improvement between ethnic groups.
Conclusion. We found exercise to benefit Hispanic and non-Hispanic subjects similarly.
Hispanic adults with diabetes had a lower incidence of heart attacks. This may be attributable to
observed anthropometric differences; however, if nutritional or behavior customs confer
cardio-protective effects in this population, future researchers need to identify those variables.
Introduction
It is estimated that 92.1 million US adults have at least one type of cardiovascular disease
(CVD) and by 2030 43.9% of the US adult population will have some form of CVD (Benjamin
et al., 2017). Hispanics account for 18.5% of the US population based on the U.S. Census
Bureau and are the fastest-growing ethnic group. They symbolize the diversity of the United
States and are expected to constitute 30% of the US population by 2050 (Rodriguez et al., 2014).
The U.S. Office of Management and Budget (OMB) defines Hispanics or Latino as “a person of
Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin
regardless of race”. Hispanic is an ethnic-based term that is independent of race
(Aguayo-Mazzucato et al., 2019). “Race mainly alludes to physical characteristics that are
genetically determined, while ethnicity relates to a perceived cultural distinctiveness, expressed
in language, music, values, art, styles, literature, family life, religion, ritual, food, naming, public
life, and culture” (Caballero, 2007). Despite their growing numbers Hispanics endure health
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disparities, specifically in categories that increase the prevalence of CVD.
In 2020, deaths attributed to CVD increased by 18.7% from 2010 to a total of
approximately 19 million (Virani et al., 2022). But, risk factors are not proportionate among all
ethnicities (Ferdinand et al., 2017). These risk factors that contribute to CVD are influential
because depending on the level they can advance the prevalence of CVD. Knowing the level of
risk factors present begins the prescription of treatment and management for preventative
measures. There are fixed risk factors such as genetics and modifiable risk factors such as
physical inactivity, unhealthful nutrition, dyslipidemia, hyperglycemia, high blood pressure,
obesity, thrombosis/smoking, kidney dysfunctions, and hypercholesterolemia (Bays, 2020). The
Center for Disease Control (CDC) presented an illustration of disparities among race and ethnic
groups in the US with hypertension and results revealed that 28% non-Hispanic whites, 41.2%
non-Hispanic blacks, 24.9% non-Hispanic Asians, and 25.9% of Hispanics had hypertension
(Figure 4). The American Heart Association reported from 2015 to 2018 US Hispanic adults 20
years of age or older who had CVD were 52.3% females and 42.7% males. There is persistent
evidence that shows Hispanics are affected by excessive rates of cardiovascular risk factors even
after adjusting for age, body mass index, and socioeconomic status (Shaw et al., 2018).
Interestingly, Hispanics have higher rates of life expectancy (Swenson et al., 2002). Thus, it is
important to elucidate how risk factors engender disease in different ethnic groups. The
identification of risk factors associated with different ethnic groups can help specify treatment
interventions more appropriately and enhance our understanding of differences that could
contribute to CVD. Such knowledge has implications for what behaviors should be modified
that are crucial in sustaining low prerequisites of CVD.
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We were interested in describing research findings on the differences in the contributions
of CVD risk factors among at-risk Hispanics and non-Hispanics. The study is ongoing, so only
the preliminary data were available for analysis.
Research Hypothesis
There will be significant differences in CVD risk factors among at-risk among at-risk
Hispanic and non-Hispanic adults.
There will be significant differences in the incidence of adverse cardiovascular events
among at-risk Hispanic and non-Hispanic adults.
Purpose
The purpose of this study is to evaluate CVD risk factors and the incidence of adverse
cardiovascular events among at-risk Hispanic and non-Hispanic adults.
Null Hypothesis
There will be no significant differences in CVD risk factors among at-risk Hispanic and
non-Hispanic adults.
There will be no significant differences in the incidence of adverse cardiovascular events
among at-risk Hispanic and non-Hispanic adults.
Delimitations
Not at-risk Hispanic and non-Hispanic adults.
Patients not diabetic.

34
Limitations
The study is not a randomized control trial.
All subjects are permitted by their physician to participate in the study.
Subject honesty when reporting ethnicity.
Review of the Literature
Cardiovascular Disease
CVD is the leading cause of morbidity and mortality in developed and undeveloped
countries regardless of race, gender, and ethnicity (Widmer et al., 2015). The CDC reported it is
responsible for 1 of every 3 deaths and estimated annual costs are 273 billion and 444 billion.
CVD is defined by the NHS as “a general term for conditions affecting the heart or blood
vessels.” It is a chronic disease that gradually develops throughout a lifetime
(Francula-Zaninovic and Nola, 2018). The American Heart Association (AHA) explained CVD
can refer to several conditions such as heart disease, heart attack, stroke, heart failure,
arrhythmia, and heart valve problems. The CDC elucidated that the most common underlying
cause of the development is atherosclerosis, a lipid storage disease where arteries become
clogged with plaque, hardening and narrowing arteries which then restricts blood flow and
oxygen supply to different parts of the body which can lead to blood clots and ultimately stroke
and heart attack. Once symptoms begin to occur CVD has more likely to progress to an
advanced stage where it causes the disability-adjusted life years leading to the loss of
productivity (Perks et al., 2012).
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Cardiovascular Risk Factors and Hispanics
CVD risk factors are separated into two categories, modifiable and non-modifiable risk
factors. Modifiable risk factors include hypertension, tobacco use, diabetes mellitus, physical
inactivity, obesity, unhealthy diet, cholesterol and lipids, depression and anxiety, and stress.
Non-modifiable risks include age, gender, genetics, and family history (Balakumar et al., 2016).
Hispanics have higher CVD risk profiles than non-Hispanics such as type 2 diabetes, obesity,
lipid abnormalities, lower socioeconomic status, and lower levels of education and physical
activity but according to death certificates, Hispanics have lower CVD mortality than
non-Hispanics (Shaw et al., 2018). For instance, Latinos, a minority group, are 15% more likely
to be obese and 65% more likely to have diabetes than non-Hispanic whites (Silfee et al., 2017).
Hispanics have higher rates of precursors of CVD and simultaneously have better life
expectancies along with lower heart disease mortality, it is a phenomenon known as the Hispanic
Paradox but why is not fully understood (Cortes-Bergoderi et al., 2013; Rodriguez et al., 2014).
The reliance on death certificates for determining the reasons for mortality has the potential to be
flawed (Cortes-Bergoderi et al., 2013). In the meta-analysis by Cortes-Bergoderi et al. (2013)
they examined; data collected from 1950 to 2009 from 341 publications of which 17 fulfilled the
inclusion criteria, 22,340,554 Hispanics, and 88,824,618 non-Hispanic whites, confirmed the
existence of the Hispanic paradox regarding CVD mortality. There are theories explaining the
paradox such as diets rich in fruit and legumes, more social support, the presence of family,
Hispanics who migrate being healthier, and Hispanics are returning to their home country to
retire or die (Shaw et al., 2017; Gallo et al., 2009). Another reason for the low mortality is a
hypothesis theory called the “salmon bias,” this is when foreign-born Hispanics who have been
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living in the United States for some time leave and return to their country of origin when their
health begins to deteriorate to live the remainder of their life, this migration leaves mortality of
US Hispanics lower (Turra et al., 2008).
Prevention of Cardiovascular Disease
CVD prevention is defined as a co-oriented set of actions, at the public and individual
level, aimed at eradicating, eliminating, or minimizing the impact of CVDs and their related
disability (Perk et al., 2012). The World Health Organization (WHO) reported reduction should
be based on three points: surveillance (map and monitor the epidemic of CVDs), prevention
(reduce exposures to risk factors), and management (equitable health care for people with CVDs)
(Alwan, 2011). Furthermore, the WHO stated mortality from CVD can be prevented by over
three-quarters by sufficient lifestyle changes. Nonmodifiable risk factors that are invariable are
age, genetics, and gender. Since those risk factors are fixed we considered the variables we can
adjust and the effect of adjustments.
Modifiable risk factors are those variables that can be affected by altering behaviors such
as terminating smoking, inadequate physical activity, obesity, high cholesterol, high triglycerides,
stress, and type 2 diabetes Metellus (Francula-Zaninovic and Nola, 2018). CVD has been
difficult to encounter and sustain improvements because of its unceasing advancement over the
years. According to Lavie et al. (2019), the leading modifiable risk factors are physical
inactivity and sedentary behavior. Increasing levels of exercise improve cardiorespiratory fitness
levels for all ages, races, ethnicity, and both sexes which is effective in the prevention of CVD
(Lavie et al., 2019). In the observational cohort study by Blair et al. (1996), it was discovered
that fit persons with a combination of smoking, high blood pressure, or elevated cholesterol had
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lower mortality rates than low-fit persons with none of the combination of factors. Hence,
exercise has an impact but adherence to it is essential to obtain the benefits. Exercise is low cost
and accessible to all. Cardiorespiratory fitness has substantial evidence supporting physiological
benefits including reduced blood pressure, improved heart rate variability, improved insulin
sensitivity, reduction in hypertension, and reduction in depression that goes well beyond the
obviation of the progression of CVD (Nauman et al., 2017).
Another strategy for encountering CVD is pharmacological measures. Data from clinical
trials have proven the effectiveness of reducing CVD and total mortality by the use of statins,
aspirin, and blood pressure-lowering agents (Bansilal et al., 2015). But, as categorized by the
WHO there are barriers to medications that source nonadherence, being patient, condition,
treatment, socioeconomic, and health system-related factors (Burkhart and Sabaté, 2003). A
randomized control trial to assess the effectiveness of the polypill-based strategy in a population
with low socioeconomic status led to reductions in systolic blood pressure and low-density
lipoprotein (LDL) cholesterol (Muñoz et al., 2019). Yet, medication treatment has a substantial
proportion of subjects who do not adhere to all cardiovascular medications as presented in the
systematic review and meta-analysis by the European Heart Journal (Chowdhury et al., 2013).
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Figure 4. Prevalence of hypertension among adults aged 18 and over, by sex and race and
Hispanic origin: the United States, 2011‐2014. Source: Centers for Disease Control and
Prevention/National Center for Health Statistics, National Health, and Nutrition Examination
Survey, 2011‐2014. https://www.cdc.gov/nchs/data/databriefs/db220.pdf
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Methodology
Subjects
The subjects in the study were all diagnosed with diabetes and were offered an exercise
and education class to treat their illness. We evaluated the effect of an exercise program
consisting of cardiovascular training, strength training, and flexibility on 67 diabetic patients. Of
the 67 subjects, 51 reported their ethnicity. Out of the 51 subjects in the program who reported
their ethnicity, 10 Hispanic and 41 non-Hispanic men and women with Type 2 diabetes were
used in the comparative analysis. The other 16 subjects that failed to report their ethnicity were
randomly assigned to one of two groups; Group 1: Attend exercise class 2x/week and prescribed
to walk for an hour 3x/week then log it, Group 2: Attend exercise class 2x/week with no
prescribed walking.
Pre-Evaluation
Patients were randomly assigned to groups and evaluated by a single clinician for
demographic and health history, anthropometric assessment (body mass index (BMI) and body
fat percentage), cardiometabolic risk factors (blood pressure, heart rate, HbA1c), tests of physical
functioning (six-minute walk test, timed up-and-go, chair stand test), strength (arm curl and
handgrip), flexibility (functional reach, sit-and-reach, back scratch). After the domains of tests,
patients completed a quality of life inventory encompassing numerous domains of life.
Exercise Program
For 10 weeks exercise classes were conducted twice per week by the clinician who did
baseline testing and assisted by student interns with expertise in group exercise classes. Each
day consisted of check-in, exercise, and cool down.
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Check-in
Upon arrival, all patients signed in and retrieved their exercise cards that displayed the
exercise program, blood pressure, blood glucose, and goal heart rate. Each patient was instructed
to obtain and report their blood glucose level according to the reading of their device. A student
intern measured patients’ systolic and diastolic blood pressure.
Aerobic Exercise
Each aerobic exercise was performed for 6 minutes. The aerobic exercise included: an
upper body extremity bike, treadmill, recumbent bike, and the Nu-Step. If the patient was not
currently on heart medication, their heart rate was reported by a fingertip oximeter following the
completion of each aerobic exercise. Patients were encouraged to exert themselves between
60-75% of maximum heart rate. If the patient was currently on heart medications, the patient
reported his or her level of exertion dependent on the Borg Rating of Perceived Exertion (range
6-20). Such patients were encouraged to exert themselves at a score between 12-14.
Resistance Exercise
Resistance exercises consisted of chest press, latissimus dorsi pulldowns, tricep
extensions, standing rows, bicep curls, wall squats, and step-ups. On the first day, each patient
was required to do one set of ten repetitions, the second day increased to two sets of ten
repetitions, and the third day increased to three sets and ten repetitions. Patients continued
performing three sets of 10 repetitions for the remainder of the program.
Cooldown
All patients participated in the cool down following the completion of aerobic and
resistance exercises. Major muscles of the upper and lower body were stretched for

41
approximately 45 seconds each. Yoga poses were incorporated during the cooldown. The
session was concluded with deep breathing exercises.
Post-Evaluation
At the end of 10 weeks, all subjects were reevaluated for anthropometric assessments,
cardiometabolic risk factors, physical functioning, strength, and flexibility. Patients in Group 1
submitted a written walking log, quantifying their participation with the walking
recommendation throughout the study. All tests were repeated by the same physician who
conducted them at baseline.
Statistical Analysis
All statistical analyses were conducted using SPSS version 24 (IBM SPSS Statistics,
IBM Corporation, Chicago IL, USA). Differences between Hispanic (n=10) and non-Hispanic
(n=41) subjects’ baseline values were evaluated using mean comparative analyses.
Independent-samples t-tests were run to compare mean differences using the continuous
variables; baseline BMI, body fat percent, baseline 6-minute walk, and baseline functional reach.
Chi-squared tests were run to identify mean differences using the categorical variables; diagnosis
of hypertension, smoking status, and categorical obesity. Subjects that failed to report their
ethnicity were excluded from the comparative analysis. Later, frequency and descriptive
statistical analyses were run using only excluded subjects. The results from the aforementioned
analyses are presented in Table 4.
Results
Overall, Hispanic subjects had greater physical functioning. The remaining variables
were higher in both mean and proportion for non-Hispanics. Previous heart attack (p=0.077) and
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baseline HbA1C (p=0.153) were not statistically significant (Table 4). Categorical variables
between Hispanics and non-Hispanics included the diagnosis of hypertension, previous heart
attack, smoking status, and categorically obese. There were significant differences between the
two subject groups for the following categorical variables; diagnosis of hypertension (p=0.002),
smoking status (p<0.001), and categorically obese (p=0.030).There were significant differences
between the two subject groups for the following continuous variables seen in Figures 6 and 7.
Analysis included baseline BMI (p=0.038), body fat percentage (p=0.021), baseline 6-minute
walk (p=0.010), and baseline functional reach (p=0.029). Of these variables smoking status,
6-minute walk, and functional reach were higher in Hispanic subjects.

Table 4
Independent samples t-test and Chi-squared test between Hispanic and Non-Hispanic patients.
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Figure 5. Difference between Hispanic and Non-Hispanic patients for categorical variables
using Chi-squared tests.
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Figure 6. Differences between Hispanic and Non-Hispanic patients for continuous
variables using Independent-samples t-tests.
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Figure 7. Differences between Hispanic and Non-Hispanic patients for the continuous variable
of the 6-minute walk test.
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Discussion
Hispanics have suffered from a tendency to have a high incidence of very high rates of
type 2 diabetes, obesity, metabolic syndrome, and multiple vascular complications (Caballero,
2007). The same study by Caballero (2007) also identified Hispanics to have a genetic tendency
to develop insulin resistance and metabolic syndrome influenced by cultural, socioeconomic,
nutritional, and lifestyle factors. Hispanics have trailed behind non-Hispanics in treatment and
are less likely to achieve well-care for diabetes and hypertension (Balfour et al., 2016). Kau et
al. (2003) examined the misuse of diabetes drugs due to the lack of health insurance and old age.
High-risk profiles in Hispanics led to attention in finding the reason for the occurrence because
of the lack of data among all Hispanic groups in the United States regarding the overall
prevalence (Rodriguez et al., 2014).
Our findings of 67 subjects indicate that ethnicity is not a factor in the control of Type 2
diabetes, a precursor of CVD. We identified differences in smoking status, the incidence of
hypertension, obesity, and physical functioning in Hispanic adults compared to non-Hispanic
adults. In the present sample of diabetic patients enrolled in the exercise program, there
appeared to be no difference in glycemic control between Hispanic and non-Hispanic subjects.
A difference we discovered was Hispanics had a lower incidence of heart attacks. This trend
may be attributable to observing anthropometric differences. However, if nutritional or
behavioral customs confer cardio-protective effects in this population, it is important for future
researchers to identify those variables.
The diabetic population is already at an increased risk of developing cardiovascular
disease. However, looking into our sample of diabetic patients there appears to be a lower risk
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for developing CVD in the Hispanic population than for non-Hispanics when using the baseline
values collected before the exercise program. Our study supports the finding that the overall
prevalence of CVD for Hispanics is lower than non-Hispanics (Rodriguez et al., 2014).
Our findings do not support higher rates of CVD risk factors among Hispanics. We
contradict the notion that Hispanics are 15% more likely to be obese and 65% more likely to
have diabetes than non-Hispanic Whites (Silfee et al., 2017). Yet, our findings support that
Hispanics experience lower CVD prevalence and mortality than non-Hispanics. As a group that
makes up a large share of the population, the National Research Council (US) Panel on Race,
Ethnicity, and Health in Later Life evaluated how the levels are perplexing since Hispanics have
lower socioeconomic status and lesser access to healthcare than non-Hispanics. Corresponding
to other literature, we observed no difference in risk of all-cause mortality (Clements et al.,
2018). Balfour et al. (2016) also found conclusions of Hispanics have low CVD prevalence and
mortality. Our similar assessment of lower levels in Hispanics can be related to the salmon bias
and contribute to the hypothesis (Guadamuz et al., 2021). This suggests that ethnicity is not a
factor in developing CVD or adverse cardiovascular events. We found this also applies to if one
is to have CVD prerequisites it is less likely of resulting to death if Hispanic. In addition, the
study points to the complexity of the Hispanic paradox and the importance of understanding it to
determine why mortality rates are low in this group.
Conclusion
There was no significant difference in CVD risk factors and the incidence of adverse
cardiovascular events among at-risk Hispanic and non-Hispanic adults. Using the baseline
values collected before the exercise program there appeared to be a lower risk for developing
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cardiovascular disease in the Hispanic population than for non-Hispanics. Understanding
differences in risk factors between various ethnicities can help identify appropriate interventions
for treatment and delimit variables of interest during treatment. The present study was limited to
a population-based sample of Hispanics within driving distance of St Joseph’s Hospital. The
sample size in this study may not be sufficient enough to present a discrepancy across both
groups. Further research is important to consider a larger sample size to evaluate.
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CHAPTER 4: THE EFFECT OF RADIATION THERAPY ON CANCER PATIENTS
PARTICIPATING IN STRUCTURED EXERCISE

Abstract
Background
Radiation therapy was first attempted as a treatment for cancer in 1896. Since then, it has
become a common modality, and the survival rate among diagnosed patients has increased
drastically. While radiation can prolong life expectancy, it can be deleterious to the patient’s
health. Exercise has consistently demonstrated improvement in anthropometric,
cardiometabolic, and functional capacities of cancer survivors, but data concerning the effect of
radiation on exercise outcomes are limited.
Purpose. To evaluate the effect of radiation therapy on exercise outcomes in cancer
survivors.
Methods. Patients participated in a 10-week exercise intervention involving aerobic,
resistance, and flexibility training. 59 patients had never used radiation (NR), 63 had complete
radiotherapy (HR), 18 currently undergoing treatment (CR), and 17 failed to report their status.
We analyzed differences among the three radiation exposure groups (NR, HR, and CR) in
baseline characteristics, exercise adherence, and improvement in several parameters of health
and function using chi-square and multivariate tests; posthoc analyses tested specific group
differences.
Results. There were no baseline differences between groups in age, health history, body
composition, cardiovascular parameters, fatigue, insomnia, or depression. Patients in the NR
group performed better on the five times sit-to-stand test than HR patients (p=0.013) and better
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on sit-and-reach (p=0.037) and functional reach (p=0.059) than CR patients. There were no
differences in program completion based on the use of radiation (p=0.404). Although there were
no baseline differences in the six-minute walk (p=0.987), CR patients improved more than HR
patients (p=0.038) and NR patients (p=0.051). There were no baseline differences in systolic
blood pressure (p=0.957) but CR patients experienced greater reductions than patients in the HR
group (p=0.011) and NR group (p=0.035).
Conclusion. Exercise may be an effective way to mitigate some of the health
consequences associated with radiation therapy. In our sample, exercise improved blood
pressure and a six-minute walk more in patients who were currently undergoing treatment;
however, our low retention rate may create potential bias and fail to accurately characterize
expected results.
Introduction
Cancer is one of the leading causes of death worldwide and the number of diagnoses is
expected to increase in the coming years. Along with the continuous increase is the expected
rise of cancer survivors (Siegel et al., 2021). Approaches for cancer treatment comprise of
radiation therapy, chemotherapy, surgery, immunotherapy, and hormonal therapy (Wang et al.,
2018). Radiation therapy (RT) also known as radiotherapy, is subject to the use of high-energy
rays or radioactive substances to damage tumoral cells and halt their growth and division
(Gianfaldoni et al., 2017). RT was first attempted by Emil Grubee as a treatment for breast
cancer in 1896 after x-rays were first discovered by Wilhelm Conrad Röntgen from Germany in
1895. Since then, it has become an essential and effective modality implemented in worldwide
cancer care, treating approximately 50% of cancer patients (Baskar et al., 2012).
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RT is the most cost-effective accounting for about 5% of total care costs (Ringborg et al.,
2003). It has been recognized as an essential element in cancer patients’ treatment for the reason
that it has the potential to improve the rates of cure of 3.5 million people each year (Jaffray and
Gospodarowicz, 2015). While RT can prolong life expectancy and aid against cancer it is
deleterious to a patient’s health. RT is associated with a negative impact on quality of life and
multiple complications in multiple health domains (Liu et al., 2017; Żmijewska-Tomczak et al.,
2014). Exercise during and after adjuvant cancer therapy serves as an effective method to
subdue negative psychological and physical side effects and symptoms, limit disease
progression, and directly benefit cancer treatment (Schmitz et al., 2010; Brown et al., 2012).
The American College of Sports Medicine (ACSM) encourages cancer survivors to
participate in 150 minutes of moderate-intensity exercise with the addition of resistance training
twice a week (Schmitz et al., 2010). A cancer survivor refers to “any person who has been
diagnosed with cancer, from the time of diagnosis through the remainder of life,” but it is
important to recognize that not all people with a history of cancer identify as survivors (Berry et
al., 2019). Only one-third of cancer survivors meet ACSM guidelines (Brown et al., 2012).
Numerous studies have explored the effect of exercise on cancer survivors, consistently
discovering that the incorporation of exercise promotes improvements in anthropometric,
cardiometabolic, and functional capacities of individuals at all stages of their cancer continuum
(Brown et al., 2012). On the contrary, data concerning the effect of radiation therapy on exercise
outcomes are limited and require further research.
With regards to the above, the study evaluated the effect of RT on exercise outcomes in
cancer survivors in a 10-week structured program.
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Research Hypothesis
Radiation therapy will have a significant effect on exercise outcomes in cancer survivors.
Purpose
To evaluate the effect of radiation therapy on exercise outcomes in cancer survivors.
Null Hypothesis
Radiation therapy will not have a significant effect on exercise outcomes in cancer
survivors.
Delimitations
People not cancer survivors or cancer patients.
Limitations
The study is not a randomized control trial.
All subjects are permitted to participate in the study.
Subject honesty when completing the Fatigue Symptom Index, Athens Insomnia
Instrument, and Zung-Self Rating Depression Scale surveys.
Review of the Literature
Overview of Cancer and Treatment
Cancer is a “multigenic and multicellular disease that can arise from all cell types and
organs with a multi-factorial etiology,” (Baskar et al., 2012). The foundation of cancer is cancer
cells, they proliferate rapidly and initiate tumors and drive tumor progression forward (Hanahan
and Weinberg, 2011). Cancer cells are resistant to anti-growth signals that prevent abnormal cell
division (Baskar and Itahana, 2017). Traditionally treatment targets those highly proliferating
mutated tumor cells and new advancements are analyzing tumor microenvironment (TME). TME
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is the cellular environment in which the tumor exists in the human system and describes the
non-cancerous cells in the tumor that affects cancer progression and is vital for identifying cell or
protein targets for cancer prevention and therapeutic purposes (Wang et al., 2018). Methods of
treatment are surgery, RT, immunotherapy, hormonal therapy, and chemotherapy (Mun et al.,
2018). Treatment is dependent on the type of cancer and what stage it is advanced and may be
combined to completely remove cancer tissues (Wang et al., 2018). It kills tumor tissues but can
also damage normal tissue leading to toxicity (De Ruysscher et al., 2019).
Radiation Therapy and its Effects
RT is the most effective cytotoxic treatment and has trifold benefits of cost-efficiency,
patient care, and organ preservation (Thariat et al., 2013). RT is delivered in different fractions
either by linear energy transfer (LET) primarily as high energy sources like photons (gamma and
X-rays), charged particles (electrons), and protons or external radiation from outside the body to
the tumor via radiation beam (Baskar and Itahana, 2017). Radiation functions as a physical
agent that damages DNA directly or indirectly produce free radicals (charged particles) that
damage the cellular DNA (Baskar et al., 2008). DNA damage is achieved by single-strand
breaks or double-strand breaks which affect signaling pathways (Baskar et al., 2014).
RT has a significant impact on survival, disease control, and treatment-related mortality
(Bradley & Mendenhall, 2018). RT has made many technological improvements since the
discovery of the x-ray in 1895 which translate to better clinical results and patient care over time
(Thariat et al., 2013). Despite advancements cancer patients have common side effects from
treatment including taste alterations, eating problems (chewing and swallowing), xerostomia,
dysphagia, trismus, hoarse voice, bone necrosis, fibrosis of soft tissue, and hearing and speech
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impairment (Żmijewska-Tomczak et al., 2014). Another impairment is reduced cognitive
function for example exhibiting difficulties with learning, memory, attention, processing speed,
and executive function (Falleti et al., 2005 & Ahles et al., 2012). As a result of treatment side
effects are negative changes to the patient’s quality of life (QoL) (Żmijewska-Tomczak et al.,
2014). The World Health Organization defines QoL as “an individual’s perception of their
position in life in the context of the culture in which they live and in relation to their goals,
expectations, standards, and concerns.” According to Siegrist and Junge, it includes physical
indicators, mental determinants, and social indicators.
Another common and distressing symptom of cancer and cancer treatment is
cancer-related fatigue (CRF) (Hilfiker et al., 2018). The National Comprehensive Cancer
Network defines CRF as “a distressing, persistent, subjective sense of physical, emotional and/or
cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to
recent activity and interferes with usual functioning.” Cancer-related fatigue is contributed by
oxidative stress, which is meticulously linked to tumor hypoxia, and acidic environments
(Ashcraft et al., 2019). Treatments to eradicate cancerous tumors can activate the
proinflammatory cytokine network in response to tissue damage from RT leading to fatigue
through cytokine signaling in the central nervous system (Bower et al., 2014).
Exercise and the Cancer Patient
In the past cancer patients were encouraged to rest if they felt adverse symptoms like
fatigue but positive findings from the first generation of oncology studies for exercise have
shifted that for its contributions to improved health, prevention of cancer regrowth, and
functional outcomes (Stout et al., 2017). Exercise is defined as “a subset of physical activity that
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is planned, structured and repetitive and that has a final or an intermediate objective of
improving or maintaining physical fitness” (Pollán et al., 2020). Exercise is not only safe and
feasible for cancer patients during and after treatment but also has direct beneficial effects linked
to the general health-promoting properties of exercise (Christensen et al., 2018). It is a relevant
intervention for patients to mitigate or prevent adverse psychological or physiological outcomes
that can lead to mortality (Mishra et al., 2012). Exercise decreases pain whereby increases
strength, cardiorespiratory fitness, and flexibility and decreases hospital stay, stress, anxiety,
insomnia disorders, and depression (Reis et al., 2018). Growing support for cancer patients and
survivors to engage in exercise led the American College of Sports Medicine (ACSM) to
assemble guidelines on exercise that are in accordance with the recommendations of the US
Physical Activity Guidelines for Americans (PAGA), which suggests at least 150 minutes a week
of moderate-intensity activity or 75 minutes a week of vigorous-intensity or an equivalent
combination (Wolin et al., 2012). It is important to note this recommendation is a long-term goal
and should not be the initial prescription for a sedentary patient (Jones et al., 2010). Sedentary
behavior and low exercise levels are associated with deconditioning, poor symptom control, and
poor clinical outcome after diagnosis (Jones et al., 2010). Silver and Gilchrist’s review discusses
how exercise improves pain and musculoskeletal issues, deconditioning and endurance effects,
fatigue, balance and falls, and psychosocial problems. The research on the association between
exercise, recurrence, and survival is limited. The summary of research by Schwartz (2012)
included 3 studies that were the first to examine the role of exercise in preventing reoccurrence
and improving survival and it provides the strength of including exercise in cancer patients’ daily
routine.
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Although many of the studies don’t demonstrate the maintenance of physical activity to
prevent adverse symptoms and side effects on many uncommon cancers there are numerous
significant studies on the most common within the population such as breast, prostate, and
colorectal, and these studies either focus on a single cancer-related impairment or a broad range
of symptoms (Stout et al., 2017). This inconsistency may be due to these cancers having the
highest percentage of diagnosis within the US population, the decreasing rate of death, and the
ability to counteract the progression of cancer within these cancer types (Siegel et al., 2019).
Even so, data is insufficient to suggest specific exercise recommendations for different cancer
groups at different stages of the cancer trajectory (Speed-Andrews et al., 2009).
It is important to note exercise eliciting beneficial changes in insulin-related pathways,
reducing inflammation and serum estrogen levels, and enhancing oxidative, immune, and cellular
repair pathways are areas of controversy because the evidence remains preliminary (Thomas et
al., 2021). Minimal evidence is known about protection against the progression of tumor growth
but possible mediators are changes in body composition, sex hormone levels, systemic
inflammation, and immune cell function (Pedersen et al., 2016). For instance, Pedersen et al.
(2016) showed a 60% reduction in tumor growth and incidence across five different tumor
models in voluntarily wheel-running tumor-bearing mice by upregulating pathways associated
with immune function, distinctively by exercise significantly increasing natural killer (NK) cell
infiltration through beta-adrenergic signaling. Exercise can regulate oxidative stress and affect
vascular normalization by increasing blood flow, metabolic programming by reducing tumors’
glucose consumption rate, and immune cell mobilization (Ashcraft et al., 2019).
The challenge oncologists encounter is tailoring the prescription of exercise such as; the
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type of exercise program suitable for the cancer type, treatment type, and how to meet FITT
(frequency, intensity, type, and time) principles while considering the functional status of the
individual (Stout et al., 2017). The most effective form of exercise for cancer patients is one that
is individually prescribed and supervised as a therapeutic program as it happens for drug
treatments (Ferioli et al., 2018). Yet, recommendations alone aren’t enough to get cancer
patients or survivors to exercise, another strategy like an exercise packet or referral can further
increase retention to exercise (Park et al., 2015). So, maybe by strengthening the impact of
exercise, it can be established to become the norm as a means of cancer treatment modalities in
addition to treatment for oncologists to prescribe.
When examining the literature to determine what type of exercise (aerobic or resistance
training) is best for the most benefit, the data is supportive to combine both aerobic and
resistance training (Luan et al., 2019). Correspondingly, emerging studies continue to agree that
exercise improves physical functioning, symptoms of fatigue, and quality of life but evidence on
the intensity of exercise is warranted. A more specific guide for an exercise prescription can
provide transparency and stability to aid from adverse effects or comorbidities and acquire the
benefits from exercise. Determining the type is dependent on the patient’s needs, stage of
cancer, current exercise behavior, and the pre-screening outcome (Jones et al., 2010). Optimizing
these categories of an exercise program will propose to initiate high adherence, recruitment, and
retention (Speed-Andrews et al., 2009).
The variation of studies analyzes how exercise affects cancer patients acutely and
chronically. Therefore, the aim of this study was not only to contribute to the benefit of exercise
but to illustrate the impact of RT on exercise outcomes in cancer patients.
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Methodology
Subjects
157 cancer survivors participated in an exercise intervention involving aerobic,
resistance, and flexibility training. The study contained 59 patients who never used radiation
(NR), 63 who previously completed radiotherapy (PR), 18 currently undergoing treatment (CR),
and 17 individuals with an unknown radiation status. Individuals with unknown radiation status
were excluded from data analysis. Participants attended an initial evaluation, completed ten
weeks of exercise, and were retested during a post-evaluation assessment. We then compared
initial evaluation measures between post evaluations. All participants completed a form of
consent and returned a signed consent from their physician to participate in the study.
Initial Evaluation
During the initial evaluation, patients completed multiple questionnaires that established
their demographics and health history. Additionally, multiple tests determined cardiometabolic
risk factors (blood pressure, VO2 max, heart rate), anthropometric measurements (BMI and body
fat percentage), physical fitness, and psychological well-being of the individual. Four domains
of physical fitness were tested; physical functioning, endurance, strength, and flexibility. Timed
up-and-go and chair stand test determined physical functioning. The six-minute walk
determined endurance. Arm curls, handgrip, UTM push, UTM pull, and Epic Lift determined
strength. Functional reach, sit-and-reach, and back scratch determine flexibility. The Fatigue
Symptom Index, Athens Insomnia Instrument, and Zung-Self Rating Depression Scale survey
determined psychological well-being.
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Exercise Program
Patients exercised biweekly for one-hour sessions. Each exercise session consisted of
three phases: check-in, exercising, and cool down. All patients initiated training simultaneously
but followed their personalized exercise program throughout the session. Each patient had
exercise cards containing a personalized exercise program and goal heart rate for the individual.
Following rest periods, student interns performed blood pressure tests. Patients were instructed
to record their blood pressure on their exercise cards.
Check-in
Patients retrieved their exercise cards and were advised to sit in the waiting room for 5
minutes until called to enter the gym to begin exercise.
Aerobic Training
Patients exercised for six minutes at each aerobic-based exercise; treadmill, Nu-Step,
recumbent bike, and Upper Body Extremity bike, for a total of 24 minutes. Each patient was
encouraged to exert themselves to their goal heart rate, which was determined by a fingertip
pulse oximeter following the six minutes at each station. If the patient was on heart medications,
the Rating of Perceived Exertion (RPE) was recorded based on the Borg Scale.
Strength Training
Patients gradually performed resistance exercises. Ten repetitions were completed on the
first day, twenty repetitions on the second day, and thirty repetitions on the third day of exercise.
The patient continued to perform thirty repetitions (3 sets of 10) per exercise for the remaining of
the program. The exercises included chest presses, latissimus dorsi pull downs, bicep curls,
standing rows, triceps extensions, squats, and step-ups.
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Cooldown
Upon completion of all aerobic and strengthening exercises, patients recollected for the
group to cool down. Led by a head clinician or student interns, patients performed multiple
stretches of major muscle groups, yoga poses, and deep breathing exercises.
Post Evaluation
After completion of the ten weeks, all individuals were retested in all domains tested
during the initial evaluation and surveys determining psychological well-being.
Statistical Analysis
All statistical tests were conducted using SPSS version 24 (IBM SPSS Statistics, IBM
Corporation, Chicago, IL, USA). Descriptive statistics of the total sample (means, percentages,
and standard deviations) were conducted to determine patient characteristics at baseline. We
analyzed differences among the three radiation exposure groups (NR, PR, and CR) using a
one-way analysis of variance (ANOVA) in baseline characteristics and exercise adherence
(p<0.05). Post-hoc analyses tested specific group differences. Multivariate tests analyzed
improvements for pre and post-exercise programs in several parameters of health and function.
Results
Subjects
As seen in Table 5, when comparing the PR, NR, and CR groups there were no baseline
differences in age, health history, body composition, cardiovascular parameters, fatigue,
insomnia, or depression. Based on posthoc analyses, patients in the NR group performed better
on the five times sit-to-stand test than PR patients (p=0.013) and better on sit-and-reach
(p=0.037) and functional reach (p=0.059) than CR patients.
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Exercise Adherence
There were no differences in program completion based on the use of radiation
(p=0.404).
Subjects Who Completed the Ten Weeks
Although there were no baseline differences in the six-minute walk (p=0.987) figure 8
shows CR patients improved more than PR patients (p=0.038) and NR patients (p=0.051). There
were no baseline differences in systolic blood pressure (p=0.957) but CR patients experienced
greater reductions than patients in the PR group (p=0.011) and NR group (p=0.035).
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Table 5
Subject baseline characteristics and exercise adherence between the never used radiation (NR),
currently using radiation (CR), and previously used radiation (PR) groups.

Note. Using one-way analysis of variance (ANOVA) in baseline characteristics and exercise
adherence (p<0.05). The individuals (n=17) who failed to report their status are excluded from
the analysis.
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Figure 8. Changes in pre to post-6-minute walk distances between NR, CR, and PR groups are
presented
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Discussion
Exercise for the overall care and management of cancer patients has been an expanding
interest in the strength of the benefits presented through data (Pollán et al., 2020). In our
research, we found that subjects currently using radiation (CR) had greater exercise outcomes
compared to those that never used radiation (NR) and previously used radiation (PR). RT is
linked to adverse effects and side effects, fatigue being the most frequent (Lipsett et al., 2017).
So, including exercise in an individual's daily routine can alleviate those side effects that
decrease quality of life and function. Our study is significant because it demonstrates the impact
exercise has on cancer patients. We also justify it as a useful adjuvant treatment at different
points of the course of cancer.
Exercise during treatment may be illustrated as not being sufficiently beneficial since
there is still vagueness in its relation to cancer-related fatigue (Kelley & Kelley, 2017). During
and after treatment cancer patients are underdiagnosed and undertreated from cancer-related
fatigue so obtaining benefits from exercise may be limited because they are negatively impacted
by treatment such as RT but the literature is uncertain (Thong et al., 2020). Our study displays
that belief is not completely appropriate to state. We differ because patients during treatment in
our study had the greatest improvements in blood pressure and the 6-minute walk test reflected
physical improvements. The six-minute walk test is an indicator of peak oxygen consumption, a
measurement of cardiorespiratory fitness which is an impairment cancer patients encounter
(Jones et al., 2012). Yet, in other research studies, it was determined that some subgroups of
cancer patients are too ill to adhere to prescribed exercise (Scott et al., 2018). Our low retention
rate may be parallel to those findings and be because of the illness of the cancer patient. Our
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results may be interpreted with caution given we did not include the stage of cancer development
in subjects currently undergoing RT. Nonetheless, our data support the findings that exercise is
advantageous considering that exercise prescription is individualized based on the identified
ability of the subject.
Systematic reviews, like that of Schumacher et al. (2021) stated all studies included had
an increase in performance in at least 1 domain of a physical function. However, more recent a
systematic review of 1563 cancer patients completed trials of combining exercise and RT and
concluded that combining both was safe and well-tolerated with improvements in
patient-reported outcomes for patients with breast, prostate, and head and neck cancer (Zaorsky
et al., 2021). In agreement with previous findings, we found that there is positive gain to have
from exercise at every level of cancer diagnosis, during radiation being the greatest. This allows
cancer patients and survivors to be independent and perform daily activities without restrictions.
Poor outcomes of physical fitness tests have been associated with reduced survival, poor
surgical outcomes, and treatment-related complications (Verweij et al., 2016 & Loughney et al.,
2016). For that reason exercise is recognized as essential for the cancer patient. Effects of
exercise have demonstrated better symptom-related outcomes, reduced inflammatory
biomarkers, declined fatigue, increased quality of life, and increased physical function, while
also playing a role in preventing tumor progression (Ashcraft et al., 2019).
Conclusion
A structured, comprehensive exercise program of aerobic and strength training performed
at moderate intensity improved blood pressure and six-minute walk more in patients who were
currently undergoing radiation treatment in comparison to an individual not undergoing radiation
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therapy at the time and individuals who never used radiation. This further solidifies the
incorporation of exercise as an essential adjunct therapy for cancer patients or survivors, and an
effective way to mitigate some of the health consequences associated with radiation therapy.
However, we recognize that our low retention rate may create potential bias and fail to accurately
characterize expected results.
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CHAPTER 5: CONCLUSION

I specified my objective for this thesis was to bring additional findings to 3 questions
with limited data. The questions included are is structured exercise effective in improving
cardiovascular, anthropometric, and functional capabilities in cancer survivors, are Hispanics
more vulnerable to CVD risk factors and the incidence of adverse cardiovascular events, and
how does RT affect structured exercise outcomes in cancer survivors. Cancer and CVD, are the
two utmost impactful diseases people encounter worldwide. These findings allow for the
significance of the interrelationship of ethnicity, treatment, and structured exercise in these
populations to illustrate the positive impact on disease risk and consequences.
In the study examining cancer patients’ effects of participating in a structured exercise
program exercise did not affect anthropometric or cardiovascular profiles, but improved physical
functioning in 11 of 13 domains. These findings are useful to help guide clinicians in exercise
prescription and planning for cancer patients. The results exhibited favorable improvements in
strength, aerobic capacity, and flexibility at follow-up when compared to baseline. Findings
align with current research on the benefits of exercise.
When evaluating the role of ethnicity in developing CVD we used a structured exercise
program to identify risk factors and adverse events. We found exercise to benefit Hispanic and
non-Hispanic subjects similarly. Our study demonstrated Hispanics may not be more vulnerable
to CVD risk factors or adverse cardiovascular effects. There was no significant difference in
CVD risk factors and the incidence of adverse cardiovascular events among at-risk Hispanic and
non-Hispanic adults. Using the baseline values collected before the exercise program there
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appeared to be a lower risk for developing cardiovascular disease in the Hispanic population than
for non-Hispanics, which contradicts some of the current literature. Understanding differences in
risk factors between various ethnicities can help identify appropriate interventions for treatment
and delimit variables of interest during treatment.
The final study analyzed cancer patients undergoing radiation treatment and exercise
outcomes. Cancer treatment includes exposure to consequences and adverse events. Our results
concluded exercise may be an effective way to mitigate some of the health consequences
associated with the treatment of radiation therapy. We also display support for the prescription
of exercise during all stages of cancer since there was an improvement for all groups in the study.
Additionally, support for the incorporation of exercise as an essential adjunct therapy for cancer
patients or survivors.
The findings allude to the assumption that these clinical populations of type-2 diabetics
and cancer patients face consequences, which are not expressed disproportionate based on
ethnicity. The consequences are detrimental to their health and daily routines, but structured
exercise similarly improves functional abilities and mitigates those consequences to allow for
independence.
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